This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Sapporo Medical University, Sumitomo Dainippon Pharma Co., Ltd.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 36 
1 out of 110 Years Active: 2020-2026
Title: The Innovative Contributions of Takayuki Kanaseki
Introduction
Takayuki Kanaseki, an accomplished inventor based in Sapporo, Japan, has made significant strides in medical research and innovation. His primary focus revolves around oncology, specifically aimed at advancing cancer detection and treatment methods. With one patented invention to his name, Kanaseki's work promises to enhance therapeutic approaches to cancer care.
Latest Patents
Takayuki Kanaseki holds a patent for a tumor antigen peptide designed to specifically detect cancer stem cells. The invention seeks to provide a detection agent, a medicinal composition containing the tumor antigen peptide as an active ingredient, and a methodology for screening this peptide. The patent outlines peptides represented by the formula Y-X-Z and introduces a polyepitope peptide that incorporates several epitope peptides. These innovations aim to create a therapeutic agent capable of inducing cytotoxic T lymphocyte (CTL) responses, underlining Kanaseki's commitment to improving cancer treatment strategies.
Career Highlights
Over the years, Kanaseki has collaborated with notable institutions, such as Sapporo Medical University and Sumitomo Dainippon Pharma Co., Ltd. His roles at these organizations have provided him with a platform to advance his research and contribute to significant developments in medical science.
Collaborations
Throughout his career, Kanaseki has worked alongside talented colleagues, including Noriyuki Sato and Toshihiko Torigoe. These collaborations have been pivotal in fostering innovative ideas and pursuing groundbreaking research in cancer therapeutics.
Conclusion
In summary, Takayuki Kanaseki's contributions to the field of oncology through his innovative patent showcase his dedication to advancing cancer detection and treatment. His work is a testament to the impact that passionate inventors can have on medical science and public health. Through continued research and collaboration, Kanaseki aims to further enhance the landscape of cancer therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile